4 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... End Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... End Points #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Fremanezumab for ... Trial Group #EBM #Neuro ... #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
A 27-year-old man with a 2-year history of recurrent, painful skin lesions. A diagnosis of hidradenitis
A diagnosis of hidradenitis ... Clinical #Derm #IM ... #Hidradenitis # ... HidradenitisSuppurativa #NEJM